EXETER, N.H.--(BUSINESS WIRE)--CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX) today announced that it has filed definitive proxy materials with the Securities and Exchange Commission (SEC) for its 2010 Annual Meeting of Stockholders. The Company has nominated Robert Forrester, a highly qualified independent director candidate, for election to the Board of Directors at the meeting. Shareholders of record as of the close of business on April 6, 2010 are entitled to attend and vote at the meeting. The Board unanimously recommends that stockholders use the Company’s WHITE proxy card to vote FOR the CPEX Board nominee and not to return any other proxy card they may receive. The Company also mailed an open letter from the CPEX Board to all CPEX shareholders. The text of the letter is below.
